Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» diabetes
diabetes
3 Reasons This Speculative Bio-Pharma Is A Winner
Seeking Alpha
Sat, 08/11/12 - 11:30 am
MannKind
Afrezza
diabetes
type 1 diabetes
type 2 diabetes
Diabetes: Progress in artificial pancreas could save Medicare nearly $1B | MassDevice.com On Call
Fri, 08/10/12 - 01:12 am
diabetes
Pancreas
Medicare
AstraZeneca buys equal say over Amylin drugs
Reuters
Thu, 08/9/12 - 10:56 am
Amylin
AstraZeneca
diabetes
Bristol-Myers Squibb
MiMedx® Group Announces Positive Results From Diabetic Foot Ulcer Randomized Controlled Trial
Tue, 08/7/12 - 11:59 pm
MiMedx
diabetes
clinical trials
Rottenstein Law Group Disturbed by Takeda Pharmaceutical’s Resubmission of Regulatory Approval Application for Actos-Containing Drug
Digital Journal
Sat, 08/4/12 - 12:49 pm
Takeda
Actos
diabetes
type 2 diabetes
Furiex Confirms Takeda's Resubmissions Of Alogliptin NDAs To FDA
NASDAQ
Sun, 07/29/12 - 01:03 pm
Furiex Pharmaceuticals
Takeda
alogliptin
diabetes
type 2 diabetes
Obesity, Heart Disease And Diabetes - A Biotech Triumvirate To Profit From Healthcare Mega-Trends In The Medium Term
Seeking Alpha
Wed, 07/25/12 - 09:38 am
obesity
heart disease
diabetes
Amarin
MannKind
Arena Pharmaceuticals
Diabetes: Roche wins FDA nod for combo glucose meter and insulin pump
Tue, 07/24/12 - 08:50 pm
diabetes
Roche
FDA
insulin pump
glucose
Diabetes: Roche wins FDA nod for combo glucose meter and insulin pump
Tue, 07/24/12 - 08:50 pm
diabetes
Roche
FDA
insulin pump
glucose
Roche’s Lucentis Works To Treat Vision Loss From Diabetes
Bloomberg
Tue, 07/24/12 - 11:19 am
Roche
diabetes
Lucentis
vision loss
diabetic macular edema
GlaxoSmithKline says data from diabetes drug study positive
Yahoo/Fly on the Wall
Wed, 07/11/12 - 12:45 pm
GSK
diabetes
albiglutide
Diabetes: Treatment by variety | MassDevice.com On Call
Tue, 07/10/12 - 11:08 pm
diabetes
treatment
Amylin Deal Signals Diabetes Space is Hot
Motley Fool
Fri, 07/6/12 - 07:34 pm
diabetes
Amylin
M&A
Bristol-Myers Squibb
AstraZeneca
MannKind Fights On With Its Diabetes Game-Changer Afrezza
Seeking Alpha
Fri, 07/6/12 - 10:59 am
diabetes
Afrezza
inhaled insulin
MannKind
Eli Lilly: A Long-Term Growth Stock
Seeking Alpha
Mon, 07/2/12 - 10:42 am
Eli Lilly
diabetes
Bristol-Myers Squibb
Incyte
Merck
Sanofi
Novo Nordisk
Bristol-Myers Squibb and AstraZeneca Expand Diabetes Alliance Through Bristol-Myers Squibb’s Acquisition of Amylin Pharmaceuticals
Yahoo/BusinessWire
Sat, 06/30/12 - 03:28 pm
Bristol-Myers Squibb
AstraZeneca
Amylin
M&A
diabetes
Bristol-Myers To Acquire Diabetes Maker Amylin For $5.3 Billion
Bloomberg
Fri, 06/29/12 - 10:21 pm
Amylin
Bristol-Myers Squibb
M&A
diabetes
FDA: Amylin Pharma Concealed Heart Safety Risks of Key Diabetes Drug
TheStreet.com
Mon, 06/25/12 - 03:29 pm
FDA
Amylin
Byetta
diabetes
Lexicon diabetes drug meets trial goal, shares up
Reuters
Mon, 06/25/12 - 11:21 am
Lexicon
diabetes
LX4211
NVO Candidate to Step into Phase III
Yahoo/Zacks
Sat, 06/23/12 - 12:05 pm
Novo Nordisk
semaglutide
diabetes
type 2 diabetes
Pages
« first
‹ previous
…
79
80
81
82
83
84
85
86
87
…
next ›
last »